Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Imai, Kazuhiro ^a   Minamiya, Yoshihiro ^a   Goto, Akiteru ^a   Nanjo, Hiroshi ^a   Saito, Hajime ^a   Motoyama, Satoru ^a   Sato, Yusuke ^a   Kudo, Satoshi ^a   Takashima, Shinogu ^a   Kawaharada, Yasushi ^a   Kurihara, Nobuyasu ^a   Orino, Kimito ^a   Ogawa, Jun ichi ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma in situ; Lung cancer; Minimally invasive adenocarcinoma; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADENOCARCINOMA IN SITU; ADULT; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MINIMALLY INVASIVE ADENOCARCINOMA; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL;

EID: 84878006908     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-113     Document Type: Article

References (23)

1. Toonkel RL, Borczuk AC, Powell CA. TGF-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol 2010, 5:153-157. 10.1097/JTO.0b013e3181c8cc0c, 2992959, 20101143.
2. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285. 10.1097/JTO.0b013e318206a221, 21252716.
3. Giampieri S, Pinner S, Sahai E. Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res 2010, 70:3435-3439. 10.1158/0008-5472.CAN-10-0466, 2883737, 20424121.
4. Korpal M, Kang Y. Targeting the transforming growth factor-beta signaling pathway in metastatic cancer. Eur J Cancer 2010, 46:1232-1240. 10.1016/j.ejca.2010.02.040, 20307969.
5. Barthelemy-Brichant N, David JL, Bosquée L, Bury T, Seidel L, Albert A, Bartsch P, Baugnet-Mahieu L, Deneufbourg JM. Increased TGF beta1 plasma level in patients with lung cancer: potential mechanisms. Eur J Clin Invest 2002, 32:193-198. 10.1046/j.1365-2362.2002.00956.x, 11895471.
6. Lee JC, Lee KM, Kim DW, Heo DS. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 2004, 172:7335-7340.
7. Domagala-Kulawik J, Hoser G, Safianowska A, Grubek-Jaworska H, Chazan R. Elevated TGF-beta1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp (Warsz) 2006, 54:143-147.
8. Flanders KC, Wakefield LM. Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression. J Mammary Gland Biol Neoplasia 2009, 14:131-144. 10.1007/s10911-009-9122-z, 2797127, 19396528.
9. Ito M, Minamiya Y, Kawai H, Saito S, Saito H, Nakagawa T, Imai K, Hirokawa M, Ogawa J. Tumor-derived TGF beta-1 induces dendritic cell apoptosis in the sentinel lymph node. J Immunol 2006, 176:5637-5643.
10. Minamiya Y, Miura M, Hinai Y, Saito H, Ito M, Ono T, Toda H, Motoyama S, Ogawa J. Transforming growth factor-β1 29T>C genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung. Tumour Biol 2010, 31:437-441. 10.1007/s13277-010-0052-6, 20506050.
11. Imai K, Minamiya Y, Koyota S, Ito M, Saito H, Sato Y, Motoyama S, Sugiyama T, Ogawa J. Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumor-draining lymph node metastasis. J Exp Clin Cancer Res 2012, 31:3. 10.1186/1756-9966-31-3, 3298529, 22233831.
12. Sobin LH, Gospodarowicz MK, Wittekind C. (Eds): TNM Classification of Malignant Tumours 2009, New York: Wiley-Blackwell, 7.
13. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
14. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004, 10:184-190. 10.1158/1078-0432.CCR-1405-2, 14734468.
15. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S, Sugimachi K. Role of transforming growth factor-b 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999, 17:607-614.
16. Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 2001, 91:964-971. 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O, 11251948.
17. Weeks BH, He W, Olson KL, Wang XJ. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res 2001, 61:7435-7443.
18. Bonewald LF. Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Expr 1999, 9:33-44.
19. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286-1292. 10.1056/NEJM199411103311907, 7935686.
20. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990, 63:245-247. 10.1016/0092-8674(90)90155-8, 2208284.
21. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, Kondo H, Shimosato Y. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852. 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#, 7773933.
22. Maeshima AM, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 2010, 5:333-339. 10.1097/JTO.0b013e3181c8cb95, 20125041.
23. Sakurai H, Maeshima A, Watanabe S, Suzuki K, Tsuchiya R, Maeshima AM, Matsuno Y, Asamura H. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004, 28:198-206. 10.1097/00000478-200402000-00007, 15043309.